The effect of interleukin-15 on the expression of killer-cell immunoglobulin-like receptors on peripheral natural killer cells in human

Mediators of Inflammation

Volumn 11, Issue 4, 2002, Pages 219-224

  Kogure, Toshiaki ^a,b   Mantani, Naoki ^a,b   Goto, Hirozo ^c   Shimada, Yutaka ^a   Tamura, Jun'ichi ^b   Terasawa, Katsutoshi ^a  

^a TOYAMA MEDICAL AND PHARMACEUTICAL UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOYAMA   (Japan)

Author keywords

IL 15; Killer cell immunoglobulin like receptors; Natural killer cell activation

Indexed keywords

CELL RECEPTOR; INTERLEUKIN 15; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL POPULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE; NATURAL KILLER CELL; PRIORITY JOURNAL;

CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; INTERLEUKIN-15; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; RECEPTORS, IGG; RECEPTORS, IMMUNOLOGIC;

EID: 0036699845     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629350290000078     Document Type: Article

References (30)

1. Wagtmann N, Biassoni R, Cantoni C, Verdiani S, Malnati MS, Vitale M, Bottino C, Moretta L, orreta A, Long EO. Molecular clones of the p58 NK cell receptor reveal immunoglobuline-related molecules with diversity in both the extra- and intracellular domains. Immunity 1995; 2: 439-449.
2. Colonna M, Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 1995; 268: 405-408.
3. D'andrea A, Chang C, Franz-Bacon K, McClanahan T, Phillips JH, Lanier LL. Molecular cloning of NKB1 a natural killer cell receptor for HLA-B allotypes. J Immunol 1995; 155: 2306-2310.
4. Binstadt BA, Brumbaugh KM, Dick CJ, Scharenberg AM, Williams BL, Colonna M, Lanier LL, Kinet JP, Abraham RT, Leibson PJ. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity 1996; 5: 629-638.
5. Vivier E, Daeron M. Immunoreceptor tyrosine-based inhibition motifs. Immunol Today 1997; 18: 286-291.
6. Lanier LL. NK cell receptors. Annu Rev Immunol 1998; 16: 359-393.
7. Kogure T, Fujinaga H, Niizawa A, Le Xuan Hai, Shimada Y, Ochiai H, Terasawa K. Killer-cell inhibitory receptors, CD158a/b, are upregulated by interleukin-2, but not interferon-γ or interleukin-4. Mediat Inflamm 1999; 8: 295-300.
8. Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, Ahdieh M, Johnson L, Alderson MR, Watson JD, Anderson DM, Giri JG. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 1994; 264: 965-968.
9. Carson WE, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, Paxton R, Anderson D, Eisenmann J, Grabstein JK, Caligiuli MA. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 1994; 180: 1395-1403.
10. Khan LA, Kasper LH. IL-15 augments CD8+ T cell-mediated immunity against Toxoplasma gondii infection in mice. J Immunol 1996; 157: 2103-2108.
11. Warren HS, Kinnear BF, Kastelein RL, Lanier LL. Analysis of the costimulatory role of IL-2 and IL-15 in initiating proliferation of resting (CD56dim) human NK cells. J Immunol 1996; 156: 3254-3259.
12. Armitage RJ, Macduff BM, Eisenman J, Paxton R, Grabstein KH. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J Immunol 1995; 154: 483-490.
13. Kanegane H, Tosato G. Activation of naive and memory T cells by interleukin-15. Blood 1996; 88: 230-235.
14. Ogasawara K, Hida S, Azimi N, Tagaya Y, Sato T, Yokochi-Fukuda T, Waldmann TA, Taniguchi T, Taki S. Requirement for IRF-1 in the microenvironment supporting natural killer cell development. Nature 1998; 391: 700-703.
15. Puzanov I, Bennett M, Kumar V. IL-15 can substitute for the marrow microenvironment in the differentiation of natural killer cells. J Immunol 1996; 157: 4282-4285.
16. Lodolce JP, Boone DL, Chai S, Swain RE, Dassopoulos T, Trettin S, Ma A. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 1998; 5: 669-676.
17. Carson WE, Fehninger TA, Haldar S, Eckhert K, Lindemann MJ, Lai CF, Croce CM, Baumann H, Caligiuli MA. A potential role for interleukin-15 in the regulation of human natural killer cell survival. J Clin Invest 1997; 99: 937-943.
18. Ross G, Winchester RJ. Methods for enumerating lymphocyte population. In: Rose NR, Friedmann H, eds. Manual of Clinical Immunology. Washington, DC: American Society for Microbiology 1986: 213
19. Frohhn C, Schlenke P, Kirscner H. The repertoire of HLA-Cw-specific NK cell receptors CD158a/b (EB6 and GL183) in individuals with different HLA phenotypes. Immunology 1997; 92: 567-570.
20. Agostini C, Trentin L, Sancetta R, Facco M, Tassinari C, Cerutti A, Bortolin M, Milani A, Siviero M, Zambello R, Semenzato G. Interleukin-15 triggers activation and growth of the CD8 T cell pool in extravascular tissues of patients with acuired immunodeficiency syndrome. Blood 1997; 90: 1115-1123.
21. Mcinnes IB, Al-Mughales J, Field M, Leung BP, Huang FP, Dixon R, Sturrock RD, Wilkinson PC, Liew FY. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat Med 1996; 2: 175-182.
22. Dunne J, Lynch S, O'Farrelly C, Todryk S, Hegarty JE, Feighry C, Doherty DG. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15. J Immunol 2001; 167: 3129-3138.
23. Bulfone-Paus S, Ungureanu D, Pohl T, Lindner G, Paus R, Ruckert R, Krause H, Kunzendorf U. Interleukin-15 protects from lethal apoptosis in vivo. Nat Med 1997; 3: 1124-1128.
24. Moretta L, Ciccone E, Moretta A, Hoglund P, Ohlen C, Karre K. Allorecognition by NK cells: nonself or self. Immunol Today 1992; 13: 300-303.
25. Yokoyama WM, Seaman WE. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Annu Rev Immunol 1993; 11: 613-635.
26. Lanier IL, Phillips JH. Inhibitory MHC class I receptors on NK cells and T cells. Immunol Today 1996; 17: 86-91.
27. Morreta A, Poggi A, Pende D, Tripodi G, Orengo AM, Pella N, Augugliaro R, Bottino C, Ciccone E, Morreta N. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta. J Exp Med 1991; 174: 1393-1398.
28. Nakajima H, Cella M, Langen H, Friedlein A, Colonna M. Activating interactions in human NK cell recognition: the role of 2B4-CD48. Eur J Immunol 1999; 29: 1676-1683.
29. Huard B, Karlsson L, Triebel F. KIR down-regulation on NK cells is associated with down-regulation of activating receptors and NK cell inactivation. Eur J Immunol 2001; 31: 1728-1735.
30. Warren HS, Cambell AJ, Waldron JC, Lanier IL. Biphasic response of NK cells expressing both activating and inhibitory killer Ig-like receptors. Int Immunol 2001; 13: 1043-1052.